Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276080 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
A Phase 1 study, sponsored by Ranbaxy Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01276080: Completed Phase 1 study, sponsored by Ranbaxy Laboratories Limited.
NCT01276080 is a Phase 1 study that has completed, run by Ranbaxy Laboratories Limited. The registered enrollment target is 36 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01276080, a Phase 1 study, has completed, sponsored by Ranbaxy Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover study was conducted to compare the relative bioavailability of equal doses of the test and reference products under non-fasted conditions.
Interventions
- DRUG Donepezil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-10 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
What the finished NCT01276080 record still lists
NCT01276080 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 1 intervention - of which Donepezil is the first listed.
NCT01276080 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01276080 about?
NCT01276080 is a clinical study titled "Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions". This open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover study was conducted to compare the relative bioavailability of equal doses of the test and reference products under non-fasted conditions.
What is the current status of trial NCT01276080?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2009-10. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01276080?
The interventions under investigation include: Donepezil (DRUG).
Who is sponsoring clinical trial NCT01276080?
This trial is sponsored by Ranbaxy Laboratories Limited, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01276080's enrollment target sits among peer trials
36 1210th of 2000 higher than 743 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia